Henderson J, Bernier S, D'Amour P, Goltzman D
Calcium Research Laboratory, McGill University, Montreal, Quebec, Canada.
Endocrinology. 1990 Sep;127(3):1310-8. doi: 10.1210/endo-127-3-1310.
Passive immunization using antisera raised against rat PTH-like peptide [PLP-(1-34)] and rat PTH-(1-84) was used to assess and compare the roles played by PLP and PTH in modulating mineral metabolism in hypercalcemic rats bearing the Rice-500 Leydig cell tumor and in normocalcemic control animals. After immunization, plasma calcium in the tumor-bearing animals rapidly normalized and remained within the normal range for several days, plasma phosphate rose, and urinary phosphate and cAMP fell. These changes were associated with increased longevity of the tumor-bearing rats. Reduction of plasma calcium was shown to be a function of early (5 h) neutralization of PLP bioactivity in the kidney, whereas the effect of immunoneutralization of PLP in bone appeared later (24-48 h) and was more prolonged. Immunization against PTH in normocalcemic animals resulted in a hypocalcemic episode of smaller magnitude and shorter duration than that achieved in hypercalcemic animals immunized against PLP and appeared to be unassociated with neutralization of distal tubular effects. Neutralization of proximal tubular and skeletal actions of PTH appeared to occur in a manner analogous to that seen for PLP in tumor-bearing animals, but were of shorter duration. These studies suggest that in normal animals the action of PTH in the skeleton and/or on vitamin D metabolism contributes considerably more than renal transport activity to the maintenance of normocalcemia and that compensatory mechanisms rapidly restore homeostasis. PTH appears to be the major modulator of calcium homeostasis in normal rats, with PLP playing a minor role, if any. In tumor-bearing rats, mechanisms to restore calcium levels to baseline are delayed after PLP immunoneutralization, and PLP appears to be both necessary and sufficient for the hypercalcemic state.
使用针对大鼠甲状旁腺激素样肽[PLP-(1-34)]和大鼠甲状旁腺激素-(1-84)产生的抗血清进行被动免疫,以评估和比较PLP和甲状旁腺激素(PTH)在调节患有Rice-500 Leydig细胞瘤的高钙血症大鼠以及正常血钙对照动物的矿物质代谢中所起的作用。免疫后,荷瘤动物的血浆钙迅速恢复正常并在几天内保持在正常范围内,血浆磷酸盐升高,尿磷酸盐和环磷酸腺苷(cAMP)下降。这些变化与荷瘤大鼠寿命的延长有关。血浆钙的降低被证明是肾脏中PLP生物活性早期(5小时)中和的结果,而PLP在骨骼中的免疫中和作用出现较晚(24-48小时)且持续时间更长。正常血钙动物针对PTH的免疫导致的血钙降低发作幅度较小且持续时间较短,比针对PLP免疫的高钙血症动物所达到的程度要小,并且似乎与远曲小管效应的中和无关。PTH近端小管和骨骼作用的中和似乎以与荷瘤动物中PLP类似的方式发生,但持续时间较短。这些研究表明,在正常动物中,PTH在骨骼和/或对维生素D代谢的作用对维持正常血钙水平的贡献远大于肾脏转运活性,并且补偿机制能迅速恢复体内平衡。在正常大鼠中,PTH似乎是钙稳态的主要调节因子,而PLP即使有作用也很小。在荷瘤大鼠中,PLP免疫中和后将钙水平恢复到基线的机制会延迟,并且PLP似乎对高钙血症状态既是必要的也是充分的。